Ipilimumab + Androgen Deprivation Therapy in Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01377389
Recruitment Status : Completed
First Posted : June 21, 2011
Last Update Posted : April 12, 2018
Bristol-Myers Squibb
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 7, 2017
  Actual Study Completion Date : April 7, 2017